NCT06673329 2025-05-14Brodalumab in the Treatment of Immune-Related Adverse EventsColumbia UniversityPhase 1 Recruiting11 enrolled
NCT03329950 2024-03-28A Study of CDX-1140 (CD40) as Monotherapy or in Combination in Patients With Advanced MalignanciesCelldex TherapeuticsPhase 1 Completed132 enrolled
NCT02946671 2020-03-06Study of Pre-operative Combination Therapy With Mogamulizumab and Nivolumab Against Solid Cancer PatientsOsaka UniversityPhase 1 Completed16 enrolled
NCT00036790 2019-12-17Motexafin Gadolinium and Doxorubicin in Treating Patients With Advanced CancerUniversity of Wisconsin, MadisonPhase 1 Completed
NCT00413322 2015-07-08Study of PXD101 Alone and in Combination With 5-Fluorouracil (5-FU) in Patients With Advanced Solid TumorsValerio TherapeuticsPhase 1 Completed35 enrolled